• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Chemother . Experience of 101 patients with coronavirus infectious disease 2019 (COVID-19) at a tertiary care center in Japan

tetano

Editor, Senior Moderator
J Infect Chemother


. 2020 Dec 5;S1341-321X(20)30431-1.
doi: 10.1016/j.jiac.2020.11.024. Online ahead of print.
Experience of 101 patients with coronavirus infectious disease 2019 (COVID-19) at a tertiary care center in Japan


Kenta Yao[SUP] 1 [/SUP], Shinya Hasegawa[SUP] 1 [/SUP], Yasuaki Tagashira[SUP] 1 [/SUP], Akane Takamatsu[SUP] 1 [/SUP], Yuki Uenoyama[SUP] 1 [/SUP], Keiki Shimizu[SUP] 2 [/SUP], Hitoshi Honda[SUP] 3 [/SUP], Tokyo Metropolitan Tama Medical Center COVID-19 treatment team



Collaborators, Affiliations

Abstract

Introduction: Clusters of novel coronavirus infectious disease of 2019 (COVID-19) have spread to become a global pandemic imposing a significant burden on healthcare systems. The lack of an effective treatment and the emergence of varied and complicated clinical courses in certain populations have rendered treatment of patients hospitalized for COVID-19 difficult.
Methods: Tokyo Metropolitan Tama Medical Center, a public tertiary acute care center located in Tokyo, the epicenter of COVID-19 in Japan, has been admitting patients with COVID-19 since February 2020. The present, retrospective, case-series study aimed to investigate the clinical course and outcomes of patients with COVID-19 hospitalized at the study institution.
Results: In total, 101 patients with COVID-19 were admitted to our hospital to receive inpatient care. Eleven patients (10.9%) received ECMO, and nine patients (8.9%) died during hospitalization after COVID-19 was diagnosed. A history of smoking and obesity were most commonly encountered among patients with a complicated clinical course. Most patients who died requested to be transferred to advanced palliative care in the early course of their hospitalization.
Conclusions: Our experience of caring for these patients demonstrated a relatively lower mortality rate and higher survival rate in those with extracorporeal membrane oxygenation placement than previous reports from other countries and underscored the importance of proactive, advanced care planning in the early course of hospitalization.

Keywords: Advanced care planning; COVID-19; Hospitalization; Japan.
 
Back
Top Bottom